- Psilocybin and mushrooms are currently classified in the General Health Law as prohibited substances.
- The senators proposed its use for conditions such as anxiety, depression, addictions and stress.
- Alejandro Madrazo Lajous, researcher and founder of the CIDE Drug Policy program, said that psilocybin has abundant therapeutic power and there are no cases or records that it generates dependency.
Mental health problems are a serious threat that remains neglected. The main drawback is that most of the time people only focus on the physical aspect and not on the emotional side. Similarly, on many occasions patients are afraid to ask for help and months and even years go by before seeing a specialist.
Now, with regard to treatments for patients, there is a wide range of alternatives. With this in mind, Senator Alejandra Lagunes Soto Ruíz proposed the use of psilocybin and psilocybin mushrooms for conditions such as anxiety, depression, addictions and stress.
He pointed out that while there is very advanced research in the world to treat various disorders, in Mexico there is no research in this regard, and “modern medicine no longer provides an answer, at least to a large part of the population that has already become resistant to drugs. and look for new alternatives.
What do the current laws say?
At Table 3 of the Open Parliament on “Regulation in Mexico and the world of psilocybin and psilocybin mushrooms”the senator warned that, although the native peoples of our country have used psilocybin mushrooms as medicine, psilocybin and mushrooms are classified in the General Health Law as prohibited substances, which have little or no therapeutic value and are susceptible to wrong use.
Therefore, the legislator stressed that a way must be found to build a bill that regulates the use of psilocybin and psilocybin mushrooms in Mexico.
“We are talking about an ambitious project, because the bridge that unites modern medicine with traditional medicine has to be woven, that unites the requirements of regulatory entities such as COFEPRIS with the ancient wisdom of indigenous peoples.”
In the third table of the Open Parliament, the experts analyzed the consequences of the ban and the incorrect classification, in the General Health Law, on psilocybin mushrooms and psilocybin; as well as what is indicated in this regard by international standards and agreements.
Decriminalization of psilocybin mushrooms
There was also a discussion about a regulation without contravening international agreements; the route for a reclassification, regulation and decriminalization of psilocybin mushroomsin addition to how to integrate the right to health, the right to benefit from advances in science.
Dr. Juan Pablo Aguirre Quezada, in charge of the General Directorate of Legislative Analysis of the Belisario Dominguez Institutespoke about the current state of psilocybin regulation at the international level.
He stated that it is important that there is a legal framework for the management of said substance, since it brings secondary effects such as nausea, muscle weakness, or lack of coordination.
For his part, Alejandro Madrazo Lajous, researcher and founder of the CIDE Drug Policy program, said that psilocybin has abundant therapeutic power and there are no cases or records that it generates dependency. In the Law, he pointed out, the substance is misclassified.
Also read:
Quiet quitting, the new trend that defends mental health
Instagram is sued for affecting children’s mental health
Chart of the day: Social networks with the greatest influence on mental health